4586 — Medrx Co Balance Sheet
0.000.00%
- ¥3bn
- ¥2bn
- ¥258m
Annual balance sheet for Medrx Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1,812 | 1,704 | 994 | 1,721 | 1,978 |
Net Total Receivables | 37.1 | 23 | 15.2 | 33 | 44.3 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,887 | 1,755 | 1,087 | 1,785 | 2,073 |
Net Property, Plant And Equipment | 328 | 270 | 226 | 182 | 124 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,297 | 2,109 | 1,398 | 2,052 | 2,276 |
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 123 | 126 | 158 | 100 | 106 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 150 | 153 | 186 | 128 | 106 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 2,147 | 1,955 | 1,213 | 1,925 | 2,170 |
Total Liabilities & Shareholders' Equity | 2,297 | 2,109 | 1,398 | 2,052 | 2,276 |
Total Common Shares Outstanding |